The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HSCT
Clinical trial NCT03902041 · UNKNOWN
Trial details
- NCT number
- NCT03902041
- Sponsor
- Shandong Provincial Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-01
- Primary completion
- 2022-04-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.